VANGL2 and cancer: mRNA expression of VANGL2, NOS1AP and SCRIB is not prognostic of survival in breast cancer as a whole or in the subsets of luminal A, luminal B, HER2 and basal cancers (Log Rank p corrected for multiple comparisons >0.05; not shown).